SARS-CoV-2, COVID-19, Newcastle disease virus, Egg-based vaccine
COVID-19, SARS-CoV-2, whole inactivated virus vaccine, variants of concern, Ad26.COV2.S, Heterologous booster, neutralizing antibodies, delta, omicron, Thailand